Spruce Biosciences Future Growth
Future criteria checks 2/6
Spruce Biosciences's earnings are forecast to decline at 7.9% per annum while its annual revenue is expected to grow at 43.5% per year. EPS is expected to grow by 15% per annum.
Key information
-7.9%
Earnings growth rate
15.0%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 43.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 12 | -47 | N/A | -43 | 1 |
| 12/31/2025 | 1 | -43 | N/A | -39 | 3 |
| 12/31/2024 | 4 | -40 | N/A | -43 | 1 |
| 9/30/2024 | 7 | -39 | -46 | -46 | N/A |
| 6/30/2024 | 10 | -43 | -50 | -50 | N/A |
| 3/31/2024 | 10 | -47 | -36 | -36 | N/A |
| 12/31/2023 | 10 | -48 | -33 | -33 | N/A |
| 9/30/2023 | 7 | -49 | -34 | -34 | N/A |
| 6/30/2023 | 4 | -48 | -30 | -30 | N/A |
| 3/31/2023 | 2 | -47 | -42 | -42 | N/A |
| 12/31/2022 | N/A | -46 | -42 | -42 | N/A |
| 9/30/2022 | N/A | -44 | -40 | -40 | N/A |
| 6/30/2022 | N/A | -44 | -39 | -39 | N/A |
| 3/31/2022 | N/A | -44 | -39 | -39 | N/A |
| 12/31/2021 | N/A | -42 | -36 | -36 | N/A |
| 9/30/2021 | N/A | -41 | -35 | -35 | N/A |
| 6/30/2021 | N/A | -40 | -35 | -35 | N/A |
| 3/31/2021 | N/A | -34 | -30 | -30 | N/A |
| 12/31/2020 | N/A | -30 | -28 | -28 | N/A |
| 9/30/2020 | N/A | -24 | -21 | -21 | N/A |
| 6/30/2020 | N/A | -17 | -15 | -15 | N/A |
| 3/31/2020 | N/A | -15 | -14 | -14 | N/A |
| 12/31/2019 | N/A | -13 | -13 | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SPRB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SPRB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SPRB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SPRB's revenue (43.5% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: SPRB's revenue (43.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SPRB's Return on Equity is forecast to be high in 3 years time